AMRN:NASDAQ
Amarin Corporation PLC
$14.04
arrow_downward
-2.43%(-0.35) 1D
Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$14.27
High
$14.30
Low
$13.90
Mkt. cap
296.56M
Avg. vol.
73.82K
Volume
0.00
52-wk high
$20.90
52-wk low
$13.12
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Open
$14.27
High
$14.30
Low
$13.90
Mkt. cap
296.56M
Avg. vol.
73.82K
Volume
0.00
52-wk high
$20.90
52-wk low
$13.12
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
News stories
From web sources and news partners
Zacks
·
18 hours ago
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
https://www.dars.gov.et/
·
3 weeks ago
Amarin (AMRN) Holds Near $14.15 as Bulls Defend Key Support Zone - Gap Fill Strategy
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com